Official ESCRS | European Society of Cataract & Refractive Surgeons
Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Posters

Search Title by author or title

Terson syndrome: a diagnosis not to miss

Poster Details

First Author: S.Kamvasi GREECE

Co Author(s):    S. Christou   E. Maliagkani   I. Gardeli              

Abstract Details

Purpose:

To report a case of a Terson syndrome that was referred to the emergency department for vitrectomy and further evaluation.

Setting:

State Ophthalmology Clinic, 'G. Gennimatas' General Hospital of Athens, Athens, Greece

Methods:

A 71-year-old male, with poorly controlled hypertension, visited our emergency eye department due to visual deterioration in left eye during the last three days and in right eye during the last 24 hours. A slit-lamp examination had been performed by his ophthalmologist the day before and left eye vitrectomy suggested. Best corrected visual acuity was 5/10 in right eye and counting fingers in left eye. Fundoscopy demonstrated preretinal, retinal and submacular hemorrhage in right eye and vitreous, preretinal, retinal and massive submacular hemorrhage in left eye. Patient complained of severe headache during examination and emergency brain Computed Tomography(CT) was performed.

Results:

CT scan revealed a subarachnoid hemorrhage. CT Angiography demonstrated an aneurysm in the anterior communicating artery. Patient was referred to the neurosurgery clinic, where a conventional angiography of the anterior cerebral circulation was performed. The ruptured aneurysm underwent a successful embolization.

Conclusions:

Terson syndrome, intraocular hemorrhage associated with intracranial hemorrhage and elevated intracranial pressures, has been significantly correlated with elevated morbidity and mortality when compared with subarachnoid hemorrhage without intraocular bleeding. The ophthalmologists should be aware of the syndrome as they may be the first healthcare providers to examine these life-threatening cases.

Financial Disclosure:

NONE

Back to Poster listing